A detailed history of Focus Financial Network, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Focus Financial Network, Inc. holds 4,523 shares of MRNA stock, worth $173,502. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,523
Previous 5,342 15.33%
Holding current value
$173,502
Previous $663 Million 54.39%
% of portfolio
0.01%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$63.64 - $125.14 $52,121 - $102,489
-819 Reduced 15.33%
4,523 $302 Million
Q2 2024

Jul 22, 2024

BUY
$101.21 - $166.61 $809 - $1,332
8 Added 0.15%
5,342 $663 Million
Q1 2024

Apr 24, 2024

BUY
$85.37 - $115.44 $455,363 - $615,756
5,334 New
5,334 $544 Million
Q3 2023

Jul 22, 2024

SELL
$96.41 - $126.61 $71,536 - $93,944
-742 Reduced 10.2%
6,533 $675 Million
Q2 2023

Jul 22, 2024

SELL
$118.5 - $160.53 $59,250 - $80,265
-500 Reduced 6.43%
7,275 $884 Million
Q1 2023

Jul 22, 2024

BUY
$135.66 - $197.02 $330,060 - $479,349
2,433 Added 45.54%
7,775 $1.19 Billion
Q4 2022

Jul 24, 2024

BUY
$118.38 - $210.04 $293,227 - $520,269
2,477 Added 46.37%
7,819 $1.4 Billion
Q3 2022

Jul 24, 2024

SELL
$118.07 - $194.18 $51,478 - $84,662
-436 Reduced 4.63%
8,978 $1.06 Billion
Q2 2022

Jul 24, 2024

SELL
$117.13 - $176.59 $101,785 - $153,456
-869 Reduced 8.45%
9,414 $1.34 Billion
Q1 2022

Jul 24, 2024

BUY
$126.46 - $235.05 $1.3 Million - $2.42 Million
10,283 New
10,283 $1.77 Billion
Q1 2021

Jul 24, 2024

SELL
$109.18 - $185.98 $1.67 Million - $2.85 Million
-15,309 Closed
0 $0
Q4 2020

Jul 24, 2024

SELL
$65.74 - $169.86 $672,783 - $1.74 Million
-10,234 Reduced 40.07%
15,309 $1.6 Billion
Q3 2020

Jul 24, 2024

BUY
$54.34 - $94.85 $1.1 Million - $1.92 Million
20,201 Added 378.15%
25,543 $1.81 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Focus Financial Network, Inc. Portfolio

Follow Focus Financial Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focus Financial Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Focus Financial Network, Inc. with notifications on news.